RankingsPricing
  1. US-listed companies
  2. GILEAD SCIENCES, INC.
  3. Financials
  4. Stockholders' equity

GILEAD SCIENCES, INC.GILD

Market cap
$155.4B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 202419,330-15.34%
Dec 31, 202322,833+7.50%
Dec 31, 202221,240+0.81%
Dec 31, 202121,069+15.63%
Dec 31, 202018,221-19.55%
Dec 31, 201922,650+5.18%
Dec 31, 201821,534+5.04%
Dec 31, 201720,501+5.88%
Dec 31, 201619,363+1.31%
Dec 31, 201519,113+20.82%
Dec 31, 201415,819+34.69%
Dec 31, 201311,745+22.97%
Dec 31, 20129,551+39.08%
Dec 31, 20116,867+12.18%
Dec 31, 20106,122

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)